Age, apolipoprotein E4, and the risk of HIV dementia: The Hawaii Aging with HIV Cohort

Journal of Neuroimmunology

Volumn 157, Issue 1-2 SPEC. ISS., 2004, Pages 197-202

  Valcour, V ^a,c   Shikuma, C ^a   Shiramizu, B ^a   Watters, M ^a   Poff, P ^a   Selnes, O A ^b   Grove, J ^a   Liu, Y ^b   Abdul Majid, K B ^b   Gartner, S ^b   Sacktor, N ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Leahi Hospital   (United States)

Author keywords

Aging; Apolipoprotein; HIV associated dementia

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN E4;

ADULT; AGING; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGING; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COHORT STUDIES; FEMALE; HAWAII; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK;

EID: 9644278123     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.08.029     Document Type: Conference Paper

References (49)

1. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force Neurology 41 1991 778 785
2. C. Achim, E. Masliah, H. Vinters, and D. Green AD pathology in the HIV brain 9th International Conference on Alzheimer's Disease and Related Disorders, Philadelphia, PA 2004
3. APA Diagnostic and Statistical Manual of Mental Disorders 2000 American Psychiatric Association Washington, DC
4. S.W. Barger, and A.D. Harmon Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E Nature 388 1997 878 881
5. P. Bretsky, J.M. Guralnik, L. Launer, M. Albert, and T.E. Seeman The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging Neurology 60 2003 1077 1081
6. B.J. Brew Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex Aids 18 Suppl. 1 2004 S75 S78
7. B. Brew, and L. Pemberton Relationship between Alzheimer's disease and AIDS dementia complex (#472) 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA 2004
8. L. Calza, R. Manfredi, B. Farneti, and F. Chiodo Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy Int. J. Antimicrob. Agents 22 2003 54 59
9. D. Carmelli, G.E. Swan, T. Reed, B. Miller, P.A. Wolf, G.P. Jarvik, and G.D. Schellenberg Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins Neurology 50 1998 1580 1585
10. J. Chapman, J. Estupinan, A. Asherov, and L.G. Goldfarb A simple and efficient method for apolipoprotein E genotype determination Neurology 46 1996 1484 1485
11. J. Chapman, S. Vinokurov, A. Achiron, D.M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D.M. Michaelson, and A.D. Korczyn APOE genotype is a major predictor of long-term progression of disability in MS Neurology 56 2001 312 316
12. M.C. Chartier-Harlin, M. Parfitt, S. Legrain, J. Perez-Tur, T. Brousseau, A. Evans, C. Berr, O. Vidal, P. Roques, and V. Gourlet Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region Hum. Mol. Genet. 3 1994 569 574
13. C.A. Colton, L.K. Needham, C. Brown, D. Cook, K. Rasheed, J.R. Burke, W.J. Strittmatter, D.E. Schmechel, and M.P. Vitek APOE genotype-specific differences in human and mouse macrophage nitric oxide production J. Neuroimmunol. 147 2004 62 67
14. D.G. Cook, J.B. Leverenz, P.J. McMillan, J.J. Kulstad, S. Ericksen, R.A. Roth, G.D. Schellenberg, L.W. Jin, K.S. Kovacina, and S. Craft Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele Am. J. Pathol. 162 2003 313 319
15. E.H. Corder, K. Robertson, L. Lannfelt, N. Bogdanovic, G. Eggertsen, J. Wilkins, and C. Hall HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy Nat. Med. 4 1998 1182 1184
16. S. Craft, and G.S. Watson Insulin and neurodegenerative disease: shared and specific mechanisms Lancet Neurol. 3 2004 169 178
17. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat. Med. 9 2003 907 913
18. R. Diaz-Arrastia, Y. Gong, S. Fair, K.D. Scott, M.C. Garcia, M.C. Carlile, M.A. Agostini, and P.C. Van Ness Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele Arch. Neurol. 60 2003 818 822
19. O. Dunlop, A.K. Goplen, K. Liestol, B. Myrvang, H. Rootwelt, B. Christophersen, E.A. Kvittingen, and J. Maehlen HIV dementia and apolipoprotein E Acta Neurol. Scand. 95 1997 315 318
20. J.E. Eichner, S.T. Dunn, G. Perveen, D.M. Thompson, K.E. Stewart, and B.C. Stroehla Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review Am. J. Epidemiol. 155 2002 487 495
21. M.M. Esiri, S.C. Biddolph, and C.S. Morris Prevalence of Alzheimer plaques in AIDS J. Neurol. Neurosurg. Psychiatry 65 1998 29 33
22. G.B. Frisoni, L. Calabresi, C. Geroldi, A. Bianchetti, A.L. D'Acquarica, S. Govoni, C.R. Sirtori, M. Trabucchi, and G. Franceschini Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia Dementia 5 1994 240 242
23. G.B. Frisoni, M. Manfredi, C. Geroldi, G. Binetti, O. Zanetti, A. Bianchetti, and M. Trabucchi The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent J. Neurol. Neurosurg. Psychiatry 65 1998 103 106
24. S. Gancher Scales for the assessment of movement disorders R. Herndon Handbook of Neurologic Rating Scales 1997 Demos Vermande New York 81 123
25. K. Goodkin, F.L. Wilkie, M. Concha, C.H. Hinkin, S. Symes, T.T. Baldewicz, D. Asthana, R.K. Fujimura, D. Lee, M.H. van Zuilen, I. Khamis, P. Shapshak, and C. Eisdorfer Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality J. Clin. Epidemiol. 54 Suppl. 1 2001 S35 S43
26. C. Grunfeld, D.P. Kotler, R. Hamadeh, A. Tierney, J. Wang, and R.N. Pierson Hypertriglyceridemia in the acquired immunodeficiency syndrome Am. J. Med. 86 1989 27 31
27. A.M. Kilbourne, A.C. Justice, L. Rabeneck, M. Rodriguez-Barradas, and S. Weissman General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era J. Clin. Epidemiol. 54 Suppl. 1 2001 S22 S28
28. S.M. Laws, E. Hone, S. Gandy, and R.N. Martins Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription J. Neurochem. 84 2003 1215 1236
29. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
30. R. Mayeux, A.M. Saunders, S. Shea, S. Mirra, D. Evans, A.D. Roses, B.T. Hyman, B. Crain, M.X. Tang, and C.H. Phelps Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's disease centers consortium on apolipoprotein E and Alzheimer's disease N. Engl. J. Med. 338 1998 506 511
31. J.C. McArthur, N. Haughey, S. Gartner, K. Conant, C. Pardo, A. Nath, and N. Sacktor Human immunodeficiency virus-associated dementia: an evolving disease J. Neurovirology 9 2003 205 221
32. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides Nat. Genet. 14 1996 55 61
33. R. Peila, B.L. Rodriguez, and L.J. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study Diabetes 51 2002 1256 1262
34. L.A. Pfeifer, L.R. White, G.W. Ross, H. Petrovitch, and L.J. Launer Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study Neurology 58 2002 1629 1634
35. T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinisto, P. Halonen, and K. Kontula Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein N. Engl. J. Med. 333 1995 1242 1247
36. M. Prince, S. Lovestone, J. Cervilla, S. Joels, J. Powell, C. Russ, and A. Mann The association between APOE and dementia does not seem to be mediated by vascular factors Neurology 54 2000 397 402
37. A.A. Rensink, I. Otte-Holler, R. de Boer, R.R. Bosch, H.J. ten Donkelaar, R.M. de Waal, M.M. Verbeek, and B. Kremer Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes Neurobiol. Aging 25 2004 93 103
38. R.A. Samatovicz Genetics and brain injury: apolipoprotein E J. Head Trauma Rehabil. 15 2000 869 874
39. J. Saura, V. Petegnief, X. Wu, Y. Liang, and S.M. Paul Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide J. Neurochem. 85 2003 1455 1467
40. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber, and A.D. Roses Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 9649 9653
41. D. St Clair, J. Norrman, R. Perry, C. Yates, G. Wilcock, and A. Brookes Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls Neurosci. Lett. 176 1994 45 46
42. J. Stohr, G. Schindler, G. Rothe, and G. Schmitz Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of ApoE4/4 monocytes Arterioscler. Thromb. Vasc. Biol. 18 1998 1424 1432
43. L. Tong, P.L. Thornton, R. Balazs, and C.W. Cotman Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised J. Biol. Chem. 276 2001 17301 17306
44. V. Valcour, and N. Sacktor HIV-associated dementia and aging J. Ment. Health Aging 8 2002 295 306
45. V. Valcour, B. Shiramizu, C. Shikuma, P. Poff, M. Watters, J. Grove, O. Selnes, and N. Sacktor Neurocognitive function among older compared to younger HIV-1 seropositive individuals 4th International Symposium on Neurovirology, Dusseldorf, Germany 2002
46. V. Valcour, C. Shikuma, B. Shiramizu, M. Watters, P. Poff, O. Selnes, P. Holck, J. Grove, and N. Sacktor Higher frequency of dementia in older HIV+ individuals. The Hawaii Aging with HIV Cohort Neurology 63 2004 822 827
47. V.G. Valcour, C.M. Shikuma, M.R. Watters, and N.C. Sacktor Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms Aids 18 Suppl. 1 2004 S79 S86
48. R. Walli, F.D. Goebel, and T. Demant Impaired glucose tolerance and protease inhibitors Ann. Intern. Med. 129 1998 837 838
49. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539